This Project Grant award of $378,904 from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) will fund an innovative research education program titled "Developing Research Leaders in Global Infectious Diseases in Women." The program aims to address the knowledge gap in sex differences in global infectious diseases and train the next generation of clinical investigators in this field. The program has...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research (CFDA 93.855) program, is funding a $3,356,188 research project titled "IMPACT OF NEONATAL ART AND BROADLY NEUTRALIZING ANTIBODIES ON HIV-1 RESERVOIRS IN INFANTS: TOWARDS ART-FREE REMISSION." The project aims to characterize the HIV-1 proviral pool composition in neonates and infants receiving very early and enhanced early antiretroviral...
This federal Project Grant award from the Fogarty International Center (CFDA 93.989 - International Research and Research Training) provides $113,400 over 5 years to support the development of an HIV cure research program focused on adolescents living with HIV-1 in Botswana. The key objectives are to: 1) identify adolescents with low HIV reservoirs and potential for post-treatment control, 2) evaluate changes in the HIV reservoir over time and enroll eligible participants in an analytical...
This Project Grant award of $402,731 from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) aims to increase the number of physician-scientists in pediatrics or obstetrics/gynecology who can apply microbiology, immunology, and research techniques to improve reproductive, maternal, and child health. The grant will support 4 resident physicians to complete one year of laboratory-based training in immunology or...
This $756,077 Project Grant was awarded by the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865). The grant supports a 5-year research study to investigate the long-term immunologic, cardiovascular, metabolic, and neurocognitive outcomes in children and adolescents with perinatal HIV infection who have achieved viral suppression on long-term antiretroviral therapy. The research will assess...
This Project Grant award, funded by the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865), aims to develop ultra-long-acting antiretroviral drug formulations for the treatment of HIV-1 infection in pediatric populations. The $2,207,322 award, effective January 17, 2025 through December 31, 2026, supports an innovative approach to transform established oral pediatric therapies, such as...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) provides $209,750 to Emory University to leverage antibody-omics to prevent and detect tuberculosis (TB) in children affected by HIV. The overarching goals are to define antibody Fc features associated with protection from Mycobacterium tuberculosis (MTB) infection among HIV-exposed infants (Aim 1) and identify biomarkers...
This Project Grant award from the National Institute of Child Health and Human Development (NICHD), under the Child Health and Human Development Extramural Research program (CFDA 93.865), provides $232,500 to The Johns Hopkins University to conduct research on the virologic determinants of very early antiretroviral treatment responses in infants with in utero HIV-1 infection. The key objectives of this 2-year project are to create infectious molecular clones from the proviral HIV-1 DNA of...
This Project Grant award of $590,710, provided by the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865), supports research to strengthen informed consent for authentic participation in perinatal HIV research. The project aims to evaluate the use of a visual informed consent form developed to improve comprehension and decision-making among low-literacy populations affected by HIV in South Africa....
This federal Project Grant award from the National Institutes of Health (NIH) Office of the Director under the Trans-NIH Research Support program (CFDA 93.310) provides $186,319 to The Regents of the University of California, San Francisco (UCSF) to adapt and test an intervention to reduce HIV-related stigma among pregnant and postpartum women in sub-Saharan Africa. The key activities include: 1) Describing the stigma experiences and mental health impacts of women living with HIV during...
NEXT GENERATION TRAINING IN HIV RESEARCH: IMMUNITY IN THE FIRST 1000 DAYS IN MOTHER-INFANT DYADS (TIGRIS) - PROJECT SUMMARY WE PROPOSE AN INNOVATIVE AND UNIQUE HIV TRAINING PROGRAM: NEXT GENERATION TRAINING IN HIV RESEARCH: IMMUNITY IN THE FIRST 1000 DAYS IN MOTHER-INFANT DYADS" (TIGRIS). THE PROGRAM WILL LEVERAGE EXISTING NIH FUNDING TO INVESTIGATE SPECIFIC HYPOTHESES RELATED TO HOW HIV INFECTION IN THE PREGNANT WOMAN LEADS TO ADVERSE BIRTH OUTCOMES AND ENSUING PEDIATRIC IMMUNE DYSFUNCTION THROUGH RIGOROUS CLINICAL AND BASIC SCIENCE LABORATORY TRAINING. TIGRIS IS A MULTIDISCIPLINARY, INTERNATIONAL AND INTERCONTINENTAL AFRICAN HIV TRAINING PROGRAM. THE PROGRAM WILL BE IMPLEMENTED AT STELLENBOSCH UNIVERSITY (SU) IN SOUTH AFRICA ALONG WITH THE MAYO CLINIC, ROCHESTER, USA. MENTORSHIP WILL BE PROVIDED BY OUR EXTENSIVE INTERNATIONAL FACULTY IN THE US (MOREHOUSE SCHOOL OF MEDICINE, STANFORD UNIVERSITY, DUKE UNIVERSITY, WEILL CORNELL MEDICAL COLLEGE, UNIVERSITY OF CINCINNATI - CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER, SEATTLE CHILDREN'S RESEARCH INSTITUTE AND HARVARD UNIVERSITY), CANADA (UNIVERSITY OF TORONTO) AND IN THE UK (UNIVERSITIES OF CAMBRIDGE AND SURREY) TO PROVIDE LABORATORY TRAINING FOR EXISTING REGISTERED MMED, PHD AND POST-DOCTORAL FELLOWS THROUGH SHORT- AND MEDIUM-TERM LABORATORY TRAINING IN SOUTH AFRICA AND IN LMICS IN WEST, EAST AND SOUTHERN AFRICA. THIS TRAINING WILL STRENGTHEN LABORATORY INVESTIGATIONS AND GENERATE NOVEL DATA BY HAVING ACCESS TO STATE-OF-THE-ART TECHNOLOGIES AND DATA ANALYSIS. BY SO DOING, THE OVER-ARCHING AIM OF TIGRIS WILL BE TO STRENGTHEN HIV RESEARCH BY STUDYING REPRODUCTIVE AND NEONATAL IMMUNOLOGY IN AFRICA AND SPECIFICALLY AROUND MOTHER-INFANT DYADS DURING MATERNAL HIV INFECTION. TIGRIS HAS THREE SPECIFIC AIMS: 1) CREATE AND IMPLEMENT A SHORT- AND MEDIUM-TERM LABORATORY TRAINING PROGRAM IN REPRODUCTIVE IMMUNOLOGY IN THE CONTEXT OF MATERNAL HIV INFECTION IN PREGNANCY; 2) TO LAUNCH AND SUSTAIN A TWO-SEMESTER STRUCTURED DIDACTIC POST-GRADUATE COURSE IN REPRODUCTIVE AND NEONATAL IMMUNOLOGY THAT WILL SUPPLEMENT AND ENRICH EXISTING TRAINING FOR CLINICIAN SCIENTISTS, GRADUATE STUDENTS WORKING TOWARDS PHD DEGREES, AND POST-DOCTORAL FELLOWS; 3) TO CREATE BILATERAL ENGAGEMENT BETWEEN STELLENBOSCH UNIVERSITY AND THE MAYO CLINIC WITH BENIN, KENYA, MALAWI AND UGANDA. WE HAVE SUCCESSFULLY USED A D71 PLANNING GRANT TO ESTABLISH THE REPRODUCTIVE IMMUNOLOGY RESEARCH CONSORTIUM IN AFRICA AND TO HOLD STAKEHOLDER MEETINGS THAT HAS SHAPED THIS D43 APPLICATION. WE WILL CONTINUE TO LEVERAGE EXISTING FUNDED PROJECTS TO IMPLEMENT TRAINING IN REPRODUCTIVE AND NEONATAL IMMUNOLOGY RESEARCH, TO ENHANCE IMMUNOLOGY KNOWLEDGE CAPACITY AND USE OUR EXTENSIVE EXPERTISE OF TRAINING IN AFRICA FOR GRANT WRITING SESSIONS THAT WILL EQUIP YOUNG CLINICAL AND PHD-BASED RESEARCHERS IN THE FIELD OF HIV RESEARCH TO BE EMERGING GLOBAL LEADERS.